Introduction
============

Certain metabolic disorders such as diabetes and obesity are involved in the development of muscle atrophy, a decrease in the mass of skeletal muscle ([@B12]; [@B16]). It is recognized that activation of ubiquitin-proteasome proteolytic pathways induced by chronic inflammation is involved in the pathogenesis of muscle atrophy ([@B3]; [@B16]; [@B6]). MuRF-1, a muscle specific E3 ubiquitin ligases is an important regulator of ubiquitin-mediated protein degradation in skeletal muscle ([@B2]). Transcriptional factors, NF-κB and FoxO3a translocate into nucleus and subsequently upregulate transcriptional activities of MuRF-1 under certain pathological conditions ([@B3]; [@B9]; [@B24]). This suggests that inhibition of NF-κB and/or FoxO3a pathways is a promising target for preventing muscle atrophy. In addition, mitochondrial dysfunction accompanied by generation of excessive reactive oxygen species contributes to elevated oxidative stress ([@B33]) that leads to impaired skeletal muscle function and accelerated loss of muscle mass in many diseases such as disuse/inactivity, diabetes, cancer, and sarcopenia ([@B26]; [@B11]). Therefore, restoration of mitochondrial function is critical for maintaining skeletal muscle homeostasis.

Beneficial effects of aerobic exercise training on age-related muscle loss have been widely recognized ([@B28]; [@B12]). Only few studies so far have investigated the molecular basis of the beneficial effects of aerobic exercise training on the skeletal muscle health, particularly muscle proteolysis, in diabetes models. Aerobic exercise training-induced downregulation of MuRF-1 expression has been addressed ([@B4]; [@B23]); however, the clear mechanism by which exercise training modulates atrophy signaling pathways in diabetes remains unclear. In *db/db* mice, high-intensity exercise (15 m/min for 30 min for 12 weeks) was related to elevated plasma cortisol levels ([@B27]), a catabolic hormone involved in activation of protein degradation pathway. For this reason, mild-intensity exercise is a more appropriate for type 2 diabetes-related muscle atrophy.

In the present study, *db/db* mouse, a popular murine model of obesity and type 2 diabetes, was used to examine effects of exercise training on regulation of MuRF-1 and its transcriptional regulators NF-κB and FoxO3a. Additionally, we investigated whether exercise training-mediated upregulation of SIRT1-AMPKα-PGC1α (SIRT1-AMPKα-PGC1α) axis and mitochondrial biogenesis could facilitate regulation of muscle mass. We hypothesized that moderate exercise training decreases NF-κB activation and promotes mitochondrial adaptations, thus preventing skeletal muscle protein degradation in type 2 diabetes.

Materials and Methods {#s1}
=====================

Materials
---------

Primary antibodies: Akt (\#9272), phospho-Akt (Thr308) (\#4056), FoxO3a (\#2497), phospho-FoxO3a (Ser253) (\#9466), AMPKα (\#2603), phospho-AMPKα (Thr172) (\#2535), IκBα (\#4814), phosphor-IκBα (Ser32) (\#2859), K48-linkage polyubiquitin (\#4289), NF-κB p65 (\#4764), phospho-NF-κB p65 (Ser563) (\#3033), and SIRT1 (\#3931), were purchased from Cell Signaling (Danvers, MA, United States). PGC1α (ab54481) was purchased from Abcam (Cambridge, MA, United States). MuRF-1 (sc-398608) and GAPDH (sc-47724) were purchased from Santa Cruz Biotechnology (Dallas, TX, United States). Goat anti-rabbit (\#7074) and horse anti-mouse (\#7076) HRP conjugated secondary antibodies were purchased from Cell signaling (Danvers, MA, United States).

Experimental Animals
--------------------

Animal experiments were approved by the National Taiwan Normal University Institutional Animal Care and Use Committee (Approval Number: 105017). Four-week-old male diabetic C57BLKS/J (*db/db*) mice (*n* = 24) and their age-matched corresponding control (*m/m*, *n* = 12) mice were purchased from the National Laboratory Animal Center (Taipei, Taiwan). Two or three mice per cage were housed in an air-conditioned animal facility at 20 ± 2°C, 50 ± 5% humidity, and 12 h light/dark cycle with free access to water and normal chow diet (LabDiet 5058, St. Louis, MO, United States). Body weight was measured weekly. At the age of 5 weeks, *db/db* mice were divided into two groups: *db/db* mice (*n* = 12) with moderate exercise training for 8 weeks and *db/db* (*n* = 12) remained sedentary throughout the study. Animals were anesthetized by intraperitoneal injection of urethane (1500 mg/1 kg BW) followed by decapitation between 10 to 12 am. Trunk blood was collected from overnight fasted mice in non-heparinized tubes. Serum was separated by centrifugation at 3,000 rpm for 15 min and stored at -20°C. Wet muscles were removed, briefly rinsed with PBS, removed excess fluid, and weighed on a digital balance. Tibialis anterior muscles were fixed with 4% paraformaldehyde and gastrocnemius muscles were stored at -80°C for further analysis.

Moderate Exercise Training
--------------------------

Moderate exercise training used in the present study has been shown to attenuate diabetes-induced renal disease, coronary vascular dysfunction, and vascular endothelial dysfunction in *db/db* mice ([@B20],[@B21]; [@B8]). Eight weeks moderate-intensity exercise (5.2 m/min, 1 h/day, and 5 days/week for a total of 8 weeks) was started from 5-week-old. During the 1st week, mice ran on a motorized treadmill (30 min with 0° slope) and exercise duration was gradually increased from 30 min to the target of 1h (0° slope). *db/db* and *m/m* mice remained sedentary were placed on the treadmill belt for the same duration.

Intraperitoneal Glucose Tolerance Test (IPGTT) and Serum Biological Markers Measurement
---------------------------------------------------------------------------------------

IPGTT test (*n* = 6/group) was performed 2 days after the last training day. Overnight fasted (12 h) mice were given glucose (1 g/kg BW) via intraperitoneal injection. Blood samples were taken by tail snipping at 0, 15, 30, 60, and 120 min after glucose injection. Blood glucose levels were measured by ACCU-CHEK (Roche, Basel, Switzerland). Two days later, overnight fasted mice were euthanized for tissue and serum collection. Serum insulin, leptin, MCP-1, resistin, IL-6, and TNFα were measured by Milliplex map kit (Millipore, Billerica, MA, United States).

Skeletal Muscle Histology
-------------------------

Embedded tibialis anterior muscle blocks from *m/m*, *db/db*, and *db/db*+Ex groups (*n* = 4/group) were cut into 5 μm sections and stained with hematoxylin-eosin. Images were observed under a microscope and captured with a digital camera (Olympus, Tokyo, Japan). Average muscle fiber CSA of tibialis anterior muscle (3 randomly selected images per animal) was determined using ImageJ with careful manual annotations and 20--45 fibers per image were counted.

Western Blot Analyses
---------------------

Gastrocnemius muscle was cut into small pieces and homogenized in ice-cold RIPA buffer containing 1 mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail (Millipore, Billerica, MA, United States). Total protein in the homogenate was measured by the Bradford dye-binding method (Bio-Rad, Hercules, CA, United States). Homogenates of gastrocnemius muscles were separated by SDS-PAGE, transferred to nitrocellulose membrane, and incubated with appropriate antibodies. Protein bands were visualized using Chemiluminescence kit (Millipore, Billerica, MA, United States) and quantified by using the LAS-4000 mini biomolecular imager (GE HealthCare Life Sciences, Pittsburgh, PA, United States).

RNA Extraction and Real-Time PCR
--------------------------------

Total RNA was extracted from gastrocnemius muscle by using Trizol/chloroform procedure (Thermo Fisher Scientific, Waltham, MA, United States) and quantified by the NanoDrop meter. Total RNA (1 μg) was reverse transcribed into cDNAs by using cDNA synthesis kit (Bio-Rad, Hercules, CA, United States). Real-time PCR was performed using SYBR Green Master Mix kit (Applied Biosystems, Foster City, CA, United States). The PCR reaction included the following components: each primer at a concentration of 10 μM, cDNA template (16 ng), and SYBR Green Master Mix and running 40 cycles. Each cDNA sample was run in triplicate and 18s primers as an internal control were included in each run to correct sample to sample variation and to normalize mRNA levels. The relative mRNA level was quantified using StepOnePlus Real-Time system (Applied Biosystems, Foster City, CA, United States). Fold change expression was calculated according to the comparative ΔΔ*C*T method. Primer sequences are shown in **Table [1](#T1){ref-type="table"}**.

###### 

Real-time PCR primers.

  Genes    GenBank accession   Forward (5′→3′)          Reverse (5′→3′)
  -------- ------------------- ------------------------ -------------------------
  Atp5a1   NM_007505           TCTCCATGCCTCTAACACTCG    CCAGGTCAACAGACGTGTCAG
  Cox5b    NM_009942           TTCAAGGTTACTTCGCGGAGT    CGGGACTAGATTAGGGTCTTCC
  F4/80    NM_001355722        TTGTACGTGCAACTCAGGACT    GATCCCAGAGTGTTGATGCAA
  IL6      NM_031168           CTCTGGGAAATCGTGGAAAT     CCAGTTTGGTAGCATCCATC
  Ndufs8   NM_144870           AGTGGCGGCAACGTACAAG      TCGAAAGAGGTAACTTAGGGTCA
  Nrf1     NM_001164230        AGCACGGAGTGACCCAAAC      TGTACGTGGCTACATGGACCT
  Sdhb     NM_023374           AATTTGCCATTTACCGATGGGA   AGCATCCAACACCATAGGTCC
  Tfam     NM_009360           ATTCCGAAGTGTTTTTCCAGCA   TCTGAAAGTTTTGCATCTGGGT
  TNFA     NM_013693           ATGAGAAGTTCCCAAATGGC     CTCCACTTGGTGGTTTGCTA
  Uqcrc1   NM_025407           AGACCCAGGTCAGCATCTTG     GCCGATTCTTTGTTCCCTTGA
  18S      NR_003278           GGGAGCCTGAGAAACGGC       GGGTCGGGAGTGGGTAATTT

Cytochrome Oxidase (Complex IV) Activity
----------------------------------------

Crude mitochondrial fraction was extracted from gastrocnemius muscle (25 mg) using mammalian mitochondrial isolation kit (BioVision, Milpitas, CA, United States, catalog\#K288) followed by manufacturer's instructions. Protein concentration was measured by the Bradford dye-binding method (Bio-Rad, Hercules, CA, United States). Mitochondrial extract (5 μg) was mixed with reduced cytochrome c and then immediately read at 550 nm for 30 min at 30 s interval. Cytochrome oxidase activity was calculated following manufacturer's instructions (BioVision, Milpitas, CA, United States, catalog\#K287).

Statistical Analysis
--------------------

Data are expressed as means ± SEM. The statistical significance of the differences among *m/m*, *db/db*, and *db/db*+Ex groups was determined by one-way ANOVA and following *post hoc* assessment by Student-Newman--Keuls Method correction for multiple comparisons (SigmaPlot 12.0, San Jose, CA, United States). Different lowercase letters indicate significant differences among groups. The student's *t*-test was used to determine the statistical significance of the differences between *db/db* and *db/db*+Ex groups (SigmaPlot 12.0). A *P*-value less than 0.05 was considered to be statistically significant.

Results
=======

Effects of Exercise on Body Weight, Blood Glucose, Insulin, Glucose Tolerance, and Serum Biological Markers
-----------------------------------------------------------------------------------------------------------

Body weight in *db/db* and *db/db*+Ex groups were higher than *m/m* mice throughout the experiment (**Figure [1A](#F1){ref-type="fig"}**). Significantly increased fasting glucose and serum insulin levels were observed in *db/db* and *db/db*+Ex compared with *m/m* mice (**Figures [1B,C](#F1){ref-type="fig"}**). Glucose tolerance was examined by area under the curve (AUC) during IPGTT (**Figure [1D](#F1){ref-type="fig"}**). Impaired glucose tolerance was observed in *db/db* and *db/db*+Ex groups compared with *m/m* mice (**Figures [1D,E](#F1){ref-type="fig"}**). Significantly decreased leptin, MCP-1, and resistin levels were observed in *db/db* mice after moderate exercise training compared with the non-exercised group (**Table [2](#T2){ref-type="table"}**). Leptin, MCP-1, and resistin levels in *db/db*+Ex mice were 8.6, 75, and 39% lower, respectively, compared with *db/db* mice without exercise training.

![Effect of moderate exercise training on body weight body, blood glucose, insulin, and glucose tolerance. Body weight (**A**, *n* = 11--12/group), fasting glucose (**B**, *n* = 6/group), serum insulin (**C**, *n* = 11--12/group), IPGTT (**D**, *n* = 6/group), and area under the curve (AUC) calculations (**E**, *n* = 6/group) in *m/m*, *db/db*, and *db/db*+Ex groups. Values presented are mean ± SEM. Significance (*P* \< 0.05) among groups is denoted by different letters.](fphys-09-00636-g001){#F1}

###### 

Serum adipokines and chemokine.

  pg/ml      *m/m*              *db/db*             *db/db*+Ex
  ---------- ------------------ ------------------- -------------------
  Leptin     718.8 ± 100.5^a^   6640.7 ± 306.3^b^   5705.4 ± 222.0^c^
  MCP-1      1.8 ± 0.4^a^       85.6 ± 41^b^        21.3 ± 9.4^a^
  Resistin   689.0 ± 68.1^a^    978.2 ± 120^b^      593.6 ± 69.3^a^

Values are mean ± SEM. Significance (P \< 0.05) among groups is denoted by different letters

.

Effects of Exercise on Muscle Fiber Size, Muscle Weight, MuRF-1 and Ubiquitination
----------------------------------------------------------------------------------

The average CSA of tibialis anterior muscle was reduced significantly in *db/db* mice compared with *m/m* mice (**Figures [2A,B](#F2){ref-type="fig"}**). The average CSA was increased significantly in *db/db* mice after exercise training (**Figures [2A,B](#F2){ref-type="fig"}**). Muscle weights of tibialis anterior and gastrocnemius muscles in *m/m* mice were greater than *db/db* mice (**Figures [2C,D](#F2){ref-type="fig"}**). In contrast to *db/db* mice without exercise training, muscle weights of tibialis anterior and gastrocnemius muscles were increased by 26 and 16%, respectively, after moderate exercise training (**Figures [2C,D](#F2){ref-type="fig"}**). Protein levels of muscle-specific E3 ubiquitin-ligase, MuRF-1, and ubiquitin (K48-linakage polyubiquitin)-conjugated proteins were used to determine the ubiquitin-proteasome system activity. Increased MuRF-1 and K48-linakage polyubiquitin levels were markedly suppressed in *db/db* mice after moderate exercise training (**Figures [2E,F](#F2){ref-type="fig"}**).

![Effect of moderate exercise training on muscle size, muscle weight, and protein expression. Representative hematoxylin-eosin stained of tibialis anterior muscle **(Aa--c)** in *m/m*, *db/db*, and d*b/db*+Ex groups (200×). Mean cross-sectional area of tibialis anterior muscle (**B**, *n* = 4/group). Tibialis anterior **(C)** and gastrocnemius **(D)** muscle weight (*n* = 9--12/group). Representative blots of MuRF-1 and K48-linkage polyubiquitin (**E,F**, *n* = 5--8). Values presented are mean ± SEM. Significance (*P* \< 0.05) among groups is denoted by different letters.](fphys-09-00636-g002){#F2}

Effects of Exercise on NF-κB and FoxO3a Signaling Pathways
----------------------------------------------------------

Activation of IκBα via phosphorylation results in the release and nuclear translocation of active NF-κB, leading to upregulation of atrophy-related and proinflammatory genes under atrophic conditions. Phosphorylation of NF-κB and IκBα was reduced significantly in *db/db*+Ex mice compared with *db/db* mice (**Figures [3A,B](#F3){ref-type="fig"}**). Inflammatory genes including IL-6 and TNFα were markedly suppressed by moderate exercise training (**Figure [3C](#F3){ref-type="fig"}**). Furthermore, suppression of macrophage marker F4/80 at mRNA level was observed in *db/db*+Ex mice (**Figure [3C](#F3){ref-type="fig"}**). Exercise training did not affect serum IL-6 and TNFα levels in both groups (**Figure [3D](#F3){ref-type="fig"}**). FoxO3a is also involved in the transcriptional regulation of MuRF-1 expression. There was no difference in phosphorylation FoxO3a and its upstream regulator Akt between *db/db* and *db/db*+Ex groups (**Figures [3E,F](#F3){ref-type="fig"}**).

![Effect of moderate exercise training on protein expression, mRNA expression, and proinflammatory cytokines. Representative blots of NF-κB, phospho-NF-κB (Ser563), IκBα, and phospho-IκBα (Ser32), are shown **(A,B)**. The protein levels in gastrocnemius muscles are presented mean ± SEM (*n* = 5/group). IL-6, TNFα, and F4/80 mRNA expression levels in gastrocnemius muscles are expressed as mean ratio to control after normalization with 18S mRNA levels. Fold differences were calculated using the ΔΔ*C*t method. Values presented are mean ± SEM (**C**, *n* = 6--8/group, each in triplicate). Serum levels of IL-6 and TNFα (**D**, *n* = 11--12/each group). Representative blots of Akt, phospho-Akt (Thr308), FoxO3a, and phospho-FoxO3a (Ser253) are shown **(E,F)**. The protein levels in gastrocnemius muscles are presented mean ± SEM (*n* = 5--7/group). Significance (*P* \< 0.05) among groups is denoted by different letters. ^∗^*P* \< 0.05 vs. *db/db*.](fphys-09-00636-g003){#F3}

Effects of Exercise on SIRT1-AMPKα-PGC1α Axis and Mitochondrial Adaptations
---------------------------------------------------------------------------

Mitochondrial dysfunction stimulates catabolic signaling pathways and subsequently promotes skeletal muscle atrophy. SIRT1, AMPKα, and PGC1α, key regulators of energy metabolism are required for exercise training-induced increases in mitochondrial function and biogenesis. Moderate exercise training significantly increased SIRT1 and PGC1α expression and AMPKα phosphorylation in *db/db*+Ex mice (**Figures [4A,B](#F4){ref-type="fig"}**). Nrf1, Tfam, subunits of mitochondrial complexes I--V at mRNA level, and mitochondrial complex IV activity were increased significantly in response to moderate exercise training (**Figures [4C](#F4){ref-type="fig"}--[E](#F4){ref-type="fig"}**).

![Effect of moderate exercise training on protein expression, mRNA expression, and complex IV activity. Representative blots of SIRT1, PGC1α, AMPKα, and phospho-AMPKα (Thr172) are shown **(A,B)**. The protein levels in gastrocnemius muscles are presented mean ± SEM (*n* = 5--7/group). Nrf1, Tfam, and mitochondrial complexes I--V mRNA expression levels in gastrocnemius muscles are expressed as mean ratio to control after normalization with 18S mRNA levels. Fold differences were calculated using the ΔΔ*C*t method. Values presented are mean ± SEM (**C,D**, *n* = 6--8/group, each in triplicate). Cytochrome oxidase (Complex IV) activity in gastrocnemius muscle (**E**, *n* = 6/group). Significance (*P* \< 0.05) among groups is denoted by different letters. ^∗^*P* \< 0.05 vs. *db/db*.](fphys-09-00636-g004){#F4}

Discussion
==========

Increased muscle protein degradation is associated with disruption of the homeostatic regulation of muscle mass in diabetes ([@B4]; [@B31]; [@B23]). Catabolic factors such as NF-κB activation and abnormal production of inflammatory cytokines stimulate ubiquitin-proteasome proteolytic pathway ([@B6]). Regular aerobic exercise has been long known in the prevention and management of type 2 diabetes ([@B5]). The clear mechanisms of aerobic exercise training on the regulation of muscle protein degradation in diabetes model remain elusive. Here, exercise effects on NF-κB and FoxO3a signaling pathways which are involved in regulation of MuRF-1 expression have been examined in diabetic *db/db* mice. Furthermore, exercise effects on SIRT1, AMPKα, PGC1α, and mitochondria-related genes were also investigated in skeletal muscle. We demonstrated that moderate exercise training successfully inhibited muscle atrophy-related ubiquitin ligase, MuRF-1, in association with suppression of NF-κB and activation of SIRT1, thereby attenuating protein degradation in diabetes.

Beneficial effects of treadmill exercise training on decreased MuRF-1 expression as well as increased muscle weight in diabetic rodent models have been demonstrated by several studies ([@B4]; [@B23]). Our data were consistent with previous studies showing that exercise inhibited ubiquitin-mediated protein degradation in skeletal muscle via suppression of MuRF-1. To further understand the anti-atrophy effect of exercise training, NF-κB signaling and pro-inflammatory cytokines, IL-6 and TNFα, were investigated. Here, moderate exercise training suppressed NF-κB signaling and its pro-inflammatory target genes, IL-6 and TNFα in skeletal muscle of diabetic *db/db* mice. Nevertheless, moderate exercise training was not able to lower serum IL-6 and TNFα levels. Suppressed adaptive immunity including inhibition of cytokine secretion was observed in *db/db* mice, which could explain no changes in serum IL-6 and TNFα levels between *db/db* and *db/db*+Ex groups. Exercise stimulates NF-κB activation ([@B15]; [@B29]), especially during high-intensity exercise ([@B7]). For this reason, *db/db* mice performed moderate-intensity exercise training (5.2 m/min, 1 h/day) to prevent over-activation of NF-κB signaling. In this context, inflammatory responses-induced protein degradation would not be exacerbated by exercise training. In the present study, moderate exercise training is sufficient to effectively suppress NF-κB signaling and inflammation-related genes. Also, *db/db*+Ex mice displayed significantly less macrophage infiltration, demonstrated by lower F4/80 expression and MCP-1 levels. NF-κB activation plays an important role in fast-twitch fiber atrophy under atrophic conditions ([@B30]). Attenuation of muscle loss in fast-type skeletal muscle (gastrocnemius and tibialis anterior) by exercise was related to suppression of NF-kB signaling. Hence, moderate exercise training is recommended for patients with type 2 diabetes to attenuate muscle loss.

FoxOs members are important transcriptional factors involved in the regulation of MuRF-1 expression ([@B17]; [@B19]). In the present study, phosphorylation of FoxO3a and its upstream Akt were not affected by moderate exercise training. *db/db*+Ex mice still exhibited hyperglycemia, hyperinsulinemia, and impaired glucose tolerance, indicating that moderate exercise training was not able to improve insulin sensitivity. These results are consistent with previous studies employing the same exercise training program ([@B20],[@B21]; [@B8]). Taken together, our data suggest that the beneficial effect of moderate exercise training on skeletal muscle health is mediated through inhibition of NF-κB-mediated inflammation rather than through direct management of whole-body insulin sensitivity.

SIRT1 inhibits NF-κB activity directly through deacetylation ([@B32]) and/or coordinates multiple signaling pathways including AMPK, PGC-1α (peroxisome proliferator-activated receptor gamma coactivator-1α, and PPARα peroxisome proliferator-activated receptor α) to suppress NF-κB signaling ([@B13]). In the present study, suppression of NFκB signaling was likely mediated, in part, through exercise-mediated upregulation of SIRT1-AMPK-PGC1α axis. Although direct evidence is not based on exercise intervention, it has been demonstrated that anti-inflammatory compounds such as isoflavones and flavonols prevent MuRF-1-mediated muscle atrophy via suppression of NF-κB and activation of SIRT1 in C2C12 myotubes ([@B10]) and skeletal muscle of *db/db* mice ([@B18]). Therefore, SIRT1-AMPK-PGC1α axis may be a therapeutic target in inflammation-induced loss of skeletal muscle.

Mitochondrial dysfunction has been implicated in the development of disuse-induced muscle atrophy and age-related muscle loss ([@B25]; [@B11]). Mitochondrial dysfunction is frequently observed in skeletal muscle in type 2 diabetes ([@B14]; [@B22]); suggesting that restoration of mitochondrial function may help type 2 diabetic patients improve their muscle health. We showed that moderate exercise training increased SIRT1 and PGC1α expression, stimulated AMPKα activation, and subsequently upregulated Nrf1, Tfam, subunits of mitochondrial complexes at mRNA level, and mitochondrial complex IV activity in diabetic *db/db* mice. Results from the present study support the hypothesis that exercise-induced mitochondrial adaptations contribute to maintaining muscle homeostasis.

The main purpose of the study is to explore the underlying mechanism of moderate exercise training on the regulation of muscle protein degradation in type 2 diabetes; nevertheless, the diabetic model of *db/db* has its own advantages and limitations. A previous study demonstrated that insulin resistance and chronic hyperglycemia alone were not sufficient to rapidly increase muscle proteolysis by comparing two models of type 2 diabetes (*db/db* mice vs. TallyHo mice) ([@B23]). A markedly elevated corticosterone level in *db/db* mice could be the key mediator involved in activation of protein degradation pathway ([@B23]). In the present study, suppressed activation of protein degradation pathway in exercising *db/db* group may be associated with low levels of glucocorticoids. Although exercise prevents skeletal muscle protein degradation, exercise alone is insufficient to fully rescue muscle mass in leptin receptor deficient diabetic (*db/db*) mice. Impaired myoblast proliferation and differentiation in mice lacking of functional leptin receptor isoforms indicates the importance of leptin receptor in the regulation of muscle mass ([@B1]). The diabetic *db/db* mice have less muscle mass compared to their age-matched corresponding control due to impairment of muscle growth and development, and that a limitation of the *db/db* mouse in translational the muscle atrophy research.

Loss of muscle mass can be triggered by certain pathological conditions including type 2 diabetes. Reduced muscle mass in patients with type 2 diabetes impairs their muscle function and may increase the risk of mortality ([@B24]). Inhibition of NF-κB, MuRF-1, and ubiquitin-mediated protein degradation by moderate exercise was observed in *db/db* mice. These findings provides better understand the anti-inflammatory effect of exercise training in type 2 diabetes-related muscle atrophy. Evidence from animal research supports the clinical use of moderate exercise to improve muscle health.

Conclusion
==========

In summary, moderate exercise training decreases NF-κB activation and represses inflammatory gene expression. Furthermore, exercise training triggers activation of SIRT1-AMPK-PGC1α axis and increases markers of mitochondrial biogenesis and mitochondrial complex IV activity. Exercise-mediated decrease in catabolic factors is associated with preventing activation of the ubiquitin-proteasome proteolysis pathway. In type 2 diabetes, lifestyle modification such as moderate exercise may help maintain muscle health.
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AMPKα

:   AMP-activated protein kinase α

CSA

:   cross-sectional area

FoxO3a

:   forkhead box O3

IL-6

:   interleukin 6

IPGTT

:   intraperitoneal glucose tolerance test

MCP-1

:   monocyte chemoattractant protein-1

mTOR

:   mammalian target of rapamycin

MuRF-1

:   muscle RING-finger protein-1

NF-κB

:   nuclear factor-κB

Nrf1

:   nuclear respiratory factor 1

PGC1α

:   peroxisome proliferator-activated receptor gamma coactivator 1-α

PPARα

:   peroxisome proliferator-activated receptor α

SIRT1

:   sirtuin 1

Tfam

:   mitochondrial transcription factor A
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:   tumor necrosis factor α.
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